US Cardiac Rhythm Management, Electrophysiology & Ablation Devices Market Studied in iData Research Report Available at MarketPublishers.com
15 Apr 2013 • by Natalie Aster
LONDON - In 2012, the U.S. market for cardiac rhythm management (CRM), electrophysiology and ablation devices market was valued at nearly $6.8 billion.
The CRM, electrophysiology and ablation device market includes pacemakers, cardiac resynchronization therapy (CRT) devices, implantable cardioverter defibrillators (ICDs), cardiac stimulation leads, external defibrillators, ablation catheters, diagnostic electrophysiology (EP) catheters, intracardiac ultrasound (ICE) catheters, electrophysiology (EP) stimulators, diagnostic ECG and cardiac monitoring devices. According to the report “U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation” by iData Research, over the forecast period, the CRM, electrophysiology and ablation device market will be driven by the aging population, rise in cardiac ablation procedures and adoption of advanced CRM devices. However, the aftermath of the economic recession of 2008 and the sluggish U.S. economy that followed have continued to stifle growth in the markets.
U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation
Published: February, 2013
Price: US$ 2,013.00
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
More information can be found in the report “U.S. Market for Cardiac Rhythm Managment, Electrophysiology and Ablation” by iData Research.